Am Padula
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Am Padula has a total of 45 co-authors. Here are the top co-authors by number of shared publications:
Kenneth D. Winkel
Univ Melbourne, Fac Med, Dept Pharmacol & Therapeut, Australian Venom Res Unit, Melbourne, Vic 3010, Australia
5 shared publicationsEm Leister
Pet Intensive Care Unit 1‐15 Lexington Rd Underwood Queensland 4119 Australia
4 shared publicationsEllie Leister
Anim Emergency Serv, Pet Intens Care Unit, Underwood, Qld, Australia
3 shared publicationsE. Leister
Pet Intensive Care Unit (Pet ICU), Underwood, Queensland, 4119, Australia
2 shared publicationsJoerg Henning
Univ Queensland, Sch Vet Sci, Gatton, Australia
2 shared publicationsRa Webster
Animal Emergency Service 104 Eastlake Street Carrara Queensland Australia
2 shared publications
Latest Publications
- Open Access
- 26 March 2023
- Published by Wiley in Australian Veterinary Journal
- Vol. 101 (6) , 219-224
A retrospective study of cane toad (Rhinella marina) toxicity in 190 domestic cats in Southeastern Queensland: Clinical presentations, treatments, and outcomes
ObjectiveTo report the clinical presentations, treatments and outcomes of toad toxicity in domestic cats in Southeastern Queensland, Australia. MethodsThis report describes a retrospective study of 190 cases of cane toad (Rhinella marina) toxicity in cats in south-eastern Queensland, Australia. All cases were presented for veterinary treatment between 2011 and 2020 at four specialist veterinary emergency centres in Southeast Queensland, Australia. Cane toad toxicity was diagnosed based on a history of exposure and clinical signs. ResultsDomestic short-hair breeds accounted for 53.6% of the cases. Presentation was seasonal with the highest incidence over the warmer months of the year (November - March). Hypersalivation was described in 96.3% (183/190), tachypnoea in 34.2% (65/190) and altered behaviour in 18.4% (35/190) of cases. Seizures occurred in 1% of cases. Of the 190 cases, 6.3% (12/190) were hospitalised and 0.5% (1/190) were euthanised and overall 99.5% (189/190) survived hospital discharge. Clinical significanceCane toad toxicity is relatively common in cats in Southeast Queensland and following buccal lavage the prognosis for recovery was excellent.
- 26 March 2023
- Published by Wiley in Australian Veterinary Journal
- Vol. 101 (6) , 219-224
Open AccessA retrospective study of cane toad (Rhinella marina) toxicity in 190 domestic cats in Southeastern Queensland: Clinical presentations, treatments, and outcomes
ObjectiveTo report the clinical presentations, treatments and outcomes of toad toxicity in domestic cats in Southeastern Queensland, Australia. MethodsThis report describes a retrospective study of 190 cases of cane toad (Rhinella marina) toxicity in cats in south-eastern Queensland, Australia. All cases were presented for veterinary treatment between 2011 and 2020 at four specialist veterinary emergency centres in Southeast Queensland, Australia. Cane toad toxicity was diagnosed based on a history of exposure and clinical signs. ResultsDomestic short-hair breeds accounted for 53.6% of the cases. Presentation was seasonal with the highest incidence over the warmer months of the year (November - March). Hypersalivation was described in 96.3% (183/190), tachypnoea in 34.2% (65/190) and altered behaviour in 18.4% (35/190) of cases. Seizures occurred in 1% of cases. Of the 190 cases, 6.3% (12/190) were hospitalised and 0.5% (1/190) were euthanised and overall 99.5% (189/190) survived hospital discharge. Clinical significanceCane toad toxicity is relatively common in cats in Southeast Queensland and following buccal lavage the prognosis for recovery was excellent.
- 31 August 2022
- Published by Elsevier in Journal of Comparative Pathology
- Vol. 197, 44-52
Pulmonary Histopathology in Cats and Dogs with Fatal Tick Paralysis
- 31 August 2022
- Published by Elsevier in Journal of Comparative Pathology
- Vol. 197, 44-52
Pulmonary Histopathology in Cats and Dogs with Fatal Tick Paralysis
- Open Access
- 4 July 2022
- Published by Wiley in Australian Veterinary Journal
- Vol. 100 (10) , 476-478
Safety and efficacy of a purified canine immunoglobulin G formulation for treatment of 76 cats clinically affected by the Australian paralysis tick ( Ixodes holocyclus )
Acute adverse reactions in cats administered unrefined canine paralysis tick (Ixodes holocyclus) antiserum are commonly observed by veterinarians and can lead to significant morbidity and potentially fatal. A purified antiserum canine IgG concentrate was chromatographically prepared and aseptically formulated in single doses containing the equivalent of 5 mL of unrefined tick antiserum (TAS). The IgG was used for slow intravenous infusion into clinically affected cats at multiple veterinary clinics on the eastern seaboard of Australia. Overall, 72/76 (95%) of cats survived hospital discharge, an efficacy comparable to published data. A subset of 22 cats previously treated with unrefined TAS and considered high risk were included in the dataset. The safety profile was excellent with 0/76 acute adverse reactions although 2/76 (2.6%) developed mild facial swelling within 2 h of infusion that responded to the antihistamine. In conclusion, cats intravenously infused with purified IgG from canine TAS did not exhibit the expected frequency of acute adverse reactions during infusion and it was both safe and effective for the treatment of tick paralysis in cats.
- 4 July 2022
- Published by Wiley in Australian Veterinary Journal
- Vol. 100 (10) , 476-478
Open AccessSafety and efficacy of a purified canine immunoglobulin G formulation for treatment of 76 cats clinically affected by the Australian paralysis tick ( Ixodes holocyclus )
Acute adverse reactions in cats administered unrefined canine paralysis tick (Ixodes holocyclus) antiserum are commonly observed by veterinarians and can lead to significant morbidity and potentially fatal. A purified antiserum canine IgG concentrate was chromatographically prepared and aseptically formulated in single doses containing the equivalent of 5 mL of unrefined tick antiserum (TAS). The IgG was used for slow intravenous infusion into clinically affected cats at multiple veterinary clinics on the eastern seaboard of Australia. Overall, 72/76 (95%) of cats survived hospital discharge, an efficacy comparable to published data. A subset of 22 cats previously treated with unrefined TAS and considered high risk were included in the dataset. The safety profile was excellent with 0/76 acute adverse reactions although 2/76 (2.6%) developed mild facial swelling within 2 h of infusion that responded to the antihistamine. In conclusion, cats intravenously infused with purified IgG from canine TAS did not exhibit the expected frequency of acute adverse reactions during infusion and it was both safe and effective for the treatment of tick paralysis in cats.
- Open Access
- 23 March 2022
- Published by Wiley in Australian Veterinary Journal
- Vol. 100 (7) , 318-328
A review of 91 canine and feline red‐bellied black snake (Pseudechis porphyriacus) envenomation cases and lessons for improved management
Introduction: Most cases of red‐bellied black snake (RBBS) envenomation in dogs respond favourably to treatment comprising of tiger‐brown snake antivenom (TBAV), intravenous fluid therapy, analgesia and, if indicated, mechanical ventilation and/or blood transfusion. However, there remains a subset of patients who develop fatal complications despite intensive treatment and risk factors for these occurring remain unknown. Here we present a retrospective cross‐sectional survey of 91 canine and feline RBBS envenomation cases.Methods: Cases seen between June 2010 and June 2020 were retrieved from the databases of seven practices in South East and coastal Queensland. From the canine case population, logistic regression analysis was performed to assess the impact of potential risk factors at presentation on the likelihood of death. A final multivariable model was developed using a manual backwards elimination approach based on overall likelihood ratio tests and Wald chi‐square P‐values for each variable. Where model convergence failed due to quasi‐complete separation, Firth's penalised maximum likelihood method was implemented. Such separation may occur when an outcome is completely predicted by an explanatory variable in one group.Results: Of the 88 canine cases, 7 died (8.0%), all after prognosis‐based euthanasia. Of the three feline cases, one died after unsuccessful resuscitation following cardiopulmonary arrest. Compared to survivors, dogs that died were older, exhibited pigmenturia, received antivenom later and had a higher total plasma protein (TPP), activated clotting time (ACT) and lower packed cell volume (PCV) at presentation.
- 23 March 2022
- Published by Wiley in Australian Veterinary Journal
- Vol. 100 (7) , 318-328
Open AccessA review of 91 canine and feline red‐bellied black snake (Pseudechis porphyriacus) envenomation cases and lessons for improved management
Introduction: Most cases of red‐bellied black snake (RBBS) envenomation in dogs respond favourably to treatment comprising of tiger‐brown snake antivenom (TBAV), intravenous fluid therapy, analgesia and, if indicated, mechanical ventilation and/or blood transfusion. However, there remains a subset of patients who develop fatal complications despite intensive treatment and risk factors for these occurring remain unknown. Here we present a retrospective cross‐sectional survey of 91 canine and feline RBBS envenomation cases.Methods: Cases seen between June 2010 and June 2020 were retrieved from the databases of seven practices in South East and coastal Queensland. From the canine case population, logistic regression analysis was performed to assess the impact of potential risk factors at presentation on the likelihood of death. A final multivariable model was developed using a manual backwards elimination approach based on overall likelihood ratio tests and Wald chi‐square P‐values for each variable. Where model convergence failed due to quasi‐complete separation, Firth's penalised maximum likelihood method was implemented. Such separation may occur when an outcome is completely predicted by an explanatory variable in one group.Results: Of the 88 canine cases, 7 died (8.0%), all after prognosis‐based euthanasia. Of the three feline cases, one died after unsuccessful resuscitation following cardiopulmonary arrest. Compared to survivors, dogs that died were older, exhibited pigmenturia, received antivenom later and had a higher total plasma protein (TPP), activated clotting time (ACT) and lower packed cell volume (PCV) at presentation.
- 1 July 2021
- Published by Elsevier in Journal of Comparative Pathology
- Vol. 186, 1-6
Pathology of Fatal Australian Black Snake (Pseudechis sp) Envenomation in Two Adult Dogs
- 1 July 2021
- Published by Elsevier in Journal of Comparative Pathology
- Vol. 186, 1-6
Pathology of Fatal Australian Black Snake (Pseudechis sp) Envenomation in Two Adult Dogs
- 13 January 2021
- Published by Wiley in Australian Veterinary Journal
- Vol. 99 (5) , 139-145
Successful treatment of a potentially fatal eastern brown snake (Pseudonaja textilis) envenomation in a dog with tiger‐brown snake antivenom with serial quantification of venom antigen and antivenom concentrations in serum and urine
Case report A successfully treated case of eastern brown snake (Pseudonaja textilis) envenomation in a Jack Russel Terrier dog is described with measurement of venom and antivenom concentration pre‐ and post‐treatment. Early presentation, prompt administration of tiger‐brown snake antivenom, hospitalisation and critical care monitoring lead to low morbidity and rapid recovery from a potentially fatal envenomation. Retrospective measurement of urine and serum venom and antivenom provided insight into the potential severity of the case and rapid efficacy of antivenom. Clinical significance Potentially fatal brown snakebite cases may initially present with only mild clinical signs despite having high concentrations of venom and potential for fatal outcome. Prompt treatment with antivenom is essential to prevent the development of progressive and fatal coagulopathy and paralysis.
- 13 January 2021
- Published by Wiley in Australian Veterinary Journal
- Vol. 99 (5) , 139-145
Successful treatment of a potentially fatal eastern brown snake (Pseudonaja textilis) envenomation in a dog with tiger‐brown snake antivenom with serial quantification of venom antigen and antivenom concentrations in serum and urine
Case report A successfully treated case of eastern brown snake (Pseudonaja textilis) envenomation in a Jack Russel Terrier dog is described with measurement of venom and antivenom concentration pre‐ and post‐treatment. Early presentation, prompt administration of tiger‐brown snake antivenom, hospitalisation and critical care monitoring lead to low morbidity and rapid recovery from a potentially fatal envenomation. Retrospective measurement of urine and serum venom and antivenom provided insight into the potential severity of the case and rapid efficacy of antivenom. Clinical significance Potentially fatal brown snakebite cases may initially present with only mild clinical signs despite having high concentrations of venom and potential for fatal outcome. Prompt treatment with antivenom is essential to prevent the development of progressive and fatal coagulopathy and paralysis.
- 2 August 2020
- Published by Wiley in Australian Veterinary Journal
- Vol. 98 (9) , 442-448
SnakeMap: four years of experience with a national small animal snake envenomation registry
SnakeMap is a national cloud‐based, veterinary snakebite registry. It was designed to prospectively collect data of the clinical circumstances and temporospatial information on cases of snake envenomation in dogs and cats. We herein introduce the project and summarise the data from the first 4 years of SnakeMap. The registry is a veterinary community‐based online database allowing case entry from veterinary hospitals across Australia. Registry data comprise hospital characteristics, patient characteristics, envenoming snake type, treatment and outcome variables, including time and geolocation of the snake bite. We present summative information on select key variables from the SnakeMap registry (1 July 2015 to 30 June 2019). Twenty‐eight hospitals from 6 states/territories entered 624 cases into the registry, including 419 dogs (67%) and 205 cats (33%). Bite time was available in 216 animals of which 90 (42%) were reported to be bitten in the 3 hours between 03:00 pm and 05:59 pm; median bite to presentation interval was 60 (interquartile range [IQR] 30, 211) minutes in dogs and 95 (IQR 41, 238) minutes in cats. Bites occurred in the owner's yard in 356 dogs (85%) and 53 cats (26%). A snake venom detection kit was used in 172 cases (28%) and antivenom was administered in 523 cases (85%). Most animals (n = 534, 88%) survived to discharge (median hospitalisation of 25 [IQR 16, 62] hours). SnakeMap effectively collects relevant clinical data from dogs and cats with presumed snake bite and provides locally specific information on the epidemiology of snake envenomation in small animals.
- 2 August 2020
- Published by Wiley in Australian Veterinary Journal
- Vol. 98 (9) , 442-448
SnakeMap: four years of experience with a national small animal snake envenomation registry
SnakeMap is a national cloud‐based, veterinary snakebite registry. It was designed to prospectively collect data of the clinical circumstances and temporospatial information on cases of snake envenomation in dogs and cats. We herein introduce the project and summarise the data from the first 4 years of SnakeMap. The registry is a veterinary community‐based online database allowing case entry from veterinary hospitals across Australia. Registry data comprise hospital characteristics, patient characteristics, envenoming snake type, treatment and outcome variables, including time and geolocation of the snake bite. We present summative information on select key variables from the SnakeMap registry (1 July 2015 to 30 June 2019). Twenty‐eight hospitals from 6 states/territories entered 624 cases into the registry, including 419 dogs (67%) and 205 cats (33%). Bite time was available in 216 animals of which 90 (42%) were reported to be bitten in the 3 hours between 03:00 pm and 05:59 pm; median bite to presentation interval was 60 (interquartile range [IQR] 30, 211) minutes in dogs and 95 (IQR 41, 238) minutes in cats. Bites occurred in the owner's yard in 356 dogs (85%) and 53 cats (26%). A snake venom detection kit was used in 172 cases (28%) and antivenom was administered in 523 cases (85%). Most animals (n = 534, 88%) survived to discharge (median hospitalisation of 25 [IQR 16, 62] hours). SnakeMap effectively collects relevant clinical data from dogs and cats with presumed snake bite and provides locally specific information on the epidemiology of snake envenomation in small animals.
- 10 May 2020
- Published by Wiley in Australian Veterinary Journal
- Vol. 98 (7) , 319-325
Red‐bellied black snake (Pseudechis porphyriacus) envenomation in 17 dogs: clinical signs, coagulation changes, haematological abnormalities, venom antigen levels and outcomes following treatment with a tiger‐brown snake antivenom
Background This report describes 17 cases of red‐bellied black snake envenomation (RBBS; Pseudechis porphyriacus) in dogs in south‐eastern Queensland. Patients were prospectively enrolled for the treatment with a new tiger‐brown snake antivenom 8000 units, (TBAV; Padula Serums Pty Ltd, VIC, Australia). Case Report Clinical diagnosis of RBBS envenomation was made by either snake venom detection kit, snake identification using scale counting, or owner observed dog‐snake interaction in patients with clinical signs of envenomation. An RBBS venom antigen sandwich ELISA was used to retrospectively quantify venom levels in frozen serum and urine. Mechanical ventilation was required in 11% (2/17) patients, whole blood transfusion in 12% (2/17), tissue swelling at the bite site occurred in 53% (9/17) and facial palsy in 12% (2/17). One dog was euthanised, and overall, 94% (16/17) survived to hospital discharge. Clinicopathological changes pre‐TBAV included variable haemolysis, increased CK, pigmenturia and mildly prolonged active clotting time with a median of 134 s (n = 13, range 91–206 s). Haematological profiles post envenomation revealed anaemia (6/6) and spherocytosis (5/5), which resolved without the use of corticosteroids. Pre‐TBAV, median RBBS venom antigen concentration was 22.6 ng/mL (n = 15, range 2–128) in serum and 58 ng/mL (range 1–452) in urine; RBBS venom antigen was undetectable in serum post‐TBAV in all patients. Conclusion Some RBBS envenomed dogs required, critical care including mechanical ventilation, blood transfusion, additional antivenom and prolonged hospitalisation. TBAV was effective with excellent prognosis despite stated specificity for tiger and brown snake.
- 10 May 2020
- Published by Wiley in Australian Veterinary Journal
- Vol. 98 (7) , 319-325
Red‐bellied black snake (Pseudechis porphyriacus) envenomation in 17 dogs: clinical signs, coagulation changes, haematological abnormalities, venom antigen levels and outcomes following treatment with a tiger‐brown snake antivenom
Background This report describes 17 cases of red‐bellied black snake envenomation (RBBS; Pseudechis porphyriacus) in dogs in south‐eastern Queensland. Patients were prospectively enrolled for the treatment with a new tiger‐brown snake antivenom 8000 units, (TBAV; Padula Serums Pty Ltd, VIC, Australia). Case Report Clinical diagnosis of RBBS envenomation was made by either snake venom detection kit, snake identification using scale counting, or owner observed dog‐snake interaction in patients with clinical signs of envenomation. An RBBS venom antigen sandwich ELISA was used to retrospectively quantify venom levels in frozen serum and urine. Mechanical ventilation was required in 11% (2/17) patients, whole blood transfusion in 12% (2/17), tissue swelling at the bite site occurred in 53% (9/17) and facial palsy in 12% (2/17). One dog was euthanised, and overall, 94% (16/17) survived to hospital discharge. Clinicopathological changes pre‐TBAV included variable haemolysis, increased CK, pigmenturia and mildly prolonged active clotting time with a median of 134 s (n = 13, range 91–206 s). Haematological profiles post envenomation revealed anaemia (6/6) and spherocytosis (5/5), which resolved without the use of corticosteroids. Pre‐TBAV, median RBBS venom antigen concentration was 22.6 ng/mL (n = 15, range 2–128) in serum and 58 ng/mL (range 1–452) in urine; RBBS venom antigen was undetectable in serum post‐TBAV in all patients. Conclusion Some RBBS envenomed dogs required, critical care including mechanical ventilation, blood transfusion, additional antivenom and prolonged hospitalisation. TBAV was effective with excellent prognosis despite stated specificity for tiger and brown snake.
- 24 November 2019
- Published by Wiley in Australian Veterinary Journal
- Vol. 98 (1-2) , 53-59
Tick paralysis in dogs and cats in Australia: treatment and prevention deliverables from 100 years of research
This review of tick paralysis caused by Ixodes holocyclus in Australia addresses the question: What are the key discoveries that have enabled effective treatment and prevention of tick paralysis in dogs and cats? Critical examination of 100 years of literature reveals that arguably only three achievements have advanced treatment and prevention of tick paralysis in animals. First, the most significant treatment advance was the commercial availability of tick antiserum in the 1930s. Hyperimmune serum currently remains the only specific anti‐paralysis tick therapy available to veterinarians in Australia. Second, advances in veterinary critical care have increased survival rates of the most severely affected dogs and cats. Critical care advancements have been enabled through specialised veterinary hospitals that can provide appropriate care 24 h a day, and advanced training of veterinarians, veterinary nurses and technicians. Third, perhaps that biggest advance of all in the last 100 years of research has been the commercial availability of the isooxazoline class of acaricidal preventatives in Australia specifically for I. holocyclus. This highly effective class of preventatives offers long duration of action, low cost, spot‐on or oral formulations and a low rate of adverse reactions. Animal owners and veterinarians now have the most useful tool of all – a reliable preventative. This review reveals the key events in research over the last 100 years and the tortuous pathway to delivering better treatment and preventative options for this enigmatic Australian parasite.
- 24 November 2019
- Published by Wiley in Australian Veterinary Journal
- Vol. 98 (1-2) , 53-59
Tick paralysis in dogs and cats in Australia: treatment and prevention deliverables from 100 years of research
This review of tick paralysis caused by Ixodes holocyclus in Australia addresses the question: What are the key discoveries that have enabled effective treatment and prevention of tick paralysis in dogs and cats? Critical examination of 100 years of literature reveals that arguably only three achievements have advanced treatment and prevention of tick paralysis in animals. First, the most significant treatment advance was the commercial availability of tick antiserum in the 1930s. Hyperimmune serum currently remains the only specific anti‐paralysis tick therapy available to veterinarians in Australia. Second, advances in veterinary critical care have increased survival rates of the most severely affected dogs and cats. Critical care advancements have been enabled through specialised veterinary hospitals that can provide appropriate care 24 h a day, and advanced training of veterinarians, veterinary nurses and technicians. Third, perhaps that biggest advance of all in the last 100 years of research has been the commercial availability of the isooxazoline class of acaricidal preventatives in Australia specifically for I. holocyclus. This highly effective class of preventatives offers long duration of action, low cost, spot‐on or oral formulations and a low rate of adverse reactions. Animal owners and veterinarians now have the most useful tool of all – a reliable preventative. This review reveals the key events in research over the last 100 years and the tortuous pathway to delivering better treatment and preventative options for this enigmatic Australian parasite.